Kainos Medicine, Inc. (KOSDAQ:284620)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,087.00
-105.00 (-8.81%)
At close: Aug 14, 2025

Kainos Medicine Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-7,785-12,190-15,235-15,881-16,212
Depreciation & Amortization
591.341,1521,2771,262809.72
Loss (Gain) From Sale of Assets
21.46--650.8332.01-48.87
Asset Writedown & Restructuring Costs
1,205363---
Loss (Gain) From Sale of Investments
4.53719.3265.12535.81-125.76
Loss (Gain) on Equity Investments
2,044410.11---
Stock-Based Compensation
37.56643.721,0261,9362,932
Other Operating Activities
-1,169-1,354-301.47-525.355,226
Change in Accounts Receivable
-5.42-152.2213.64--
Change in Inventory
-681.82----
Change in Income Taxes
39.867.16-85.34-23.8614.51
Change in Other Net Operating Assets
-218.91632.54-330.411,368-1,791
Operating Cash Flow
-5,917-9,709-14,221-11,296-9,195
Capital Expenditures
-5.52-0.08-3,998-1,826-1,939
Sale of Property, Plant & Equipment
--8,3511.8212.95
Sale (Purchase) of Intangibles
-266.11-206.94-100-639.29-456.41
Investment in Securities
--3,5404,8205,366-3,657
Other Investing Activities
79.3217.25-17.61-118.1685.66
Investing Cash Flow
-442.31-4,0799,0552,785-5,753
Short-Term Debt Issued
--4,9001,246-
Long-Term Debt Issued
---761.671,523
Total Debt Issued
--4,9002,0081,523
Short-Term Debt Repaid
---5,662--
Long-Term Debt Repaid
-369.63-587.23-2,944-20,918-362.66
Total Debt Repaid
-369.63-587.23-8,605-20,918-362.66
Net Debt Issued (Repaid)
-369.63-587.23-3,705-18,9101,161
Issuance of Common Stock
5,7341,643-28,28413,308
Repurchase of Common Stock
----32.4-
Other Financing Activities
-0-0--197.79
Financing Cash Flow
5,3641,056-3,7059,34214,667
Foreign Exchange Rate Adjustments
26.84229.18256.76890.71,561
Net Cash Flow
-967.83-12,503-8,6151,7211,279
Free Cash Flow
-5,922-9,709-18,220-13,122-11,134
Free Cash Flow Margin
-505.48%-1644.59%-6815.87%-10092.16%-669.76%
Free Cash Flow Per Share
-187.15-348.85-652.51-550.49-525.41
Cash Interest Paid
0.43-157.59--
Cash Income Tax Paid
2.281.091.041.030.92
Levered Free Cash Flow
-4,888-5,744-11,695-16,9271,540
Unlevered Free Cash Flow
-4,870-5,714-11,547-16,0832,588
Change in Working Capital
-866.36547.48-402.11,344-1,776
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.